Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Cerebrospinal Fluid-Restricted Oligoclonal Bands With Relapsing Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Pediatric neurology·2026
Same author

The gut microbiome in pediatric-onset acquired demyelinating syndromes by myelin oligodendrocyte glycoprotein antibody status.

Multiple sclerosis and related disorders·2026
Same author

Factors Influencing Early and Late B-Cell Repopulation After Rituximab Therapy in Pediatric Central Nervous System Inflammatory Disorders.

Pediatric neurology·2026
Same author

Higher ultra-processed food consumption is associated with higher likelihood of paediatric-onset multiple sclerosis.

Multiple sclerosis and related disorders·2026
Same author

The Use of Patient-Reported Outcome Measures in Developmental Age: A Complementary Tool for Pediatric Multiple Sclerosis Prognosis.

Neurology and therapy·2026
Same author

Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS.

Acta neuropathologica·2026

Related Experiment Video

Updated: Sep 30, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.4K

Preventing Multiple Sclerosis: The Pediatric Perspective.

Duriel Hardy1,2, Tanuja Chitnis3,4, Emmanuelle Waubant5,6

  • 1Dell Children's Medical Center of Central Texas, Austin, TX, United States.

Frontiers in Neurology
|March 14, 2022
PubMed
Summary
This summary is machine-generated.

Pediatric multiple sclerosis (MS) research explores early-life risk factors for primary prevention. Understanding these determinants is key to reducing MS incidence in children.

Keywords:
MS environmental risk factorsdemyelinating diseasemultiple sclerosispediatric multiple sclerosis (MS)preventative medicine

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.6K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.9K

Related Experiment Videos

Last Updated: Sep 30, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.4K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.6K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.9K

Area of Science:

  • Neuroimmunology
  • Pediatric Neurology
  • Preventive Medicine

Background:

  • Pediatric multiple sclerosis (MS) is a relapsing-remitting neuroinflammatory disease with significant early lesion burden.
  • Current treatments focus on secondary prevention, aiming to reduce relapses and slow disability progression.

Purpose of the Study:

  • To review key risk factors contributing to the development of pediatric MS.
  • To explore the potential for primary prevention strategies targeting early-life exposures.
  • To discuss the implications of these risk factors for MS pathogenesis.

Main Methods:

  • Literature review of early-life exposures, perinatal factors, and environmental determinants in pediatric MS.
  • Analysis of proposed roles of these factors in MS pathogenesis.
  • Examination of potential primary prevention strategies.

Main Results:

  • Identified key perinatal and environmental risk factors associated with pediatric MS development.
  • Discussed the proposed mechanisms by which these factors may contribute to MS pathogenesis.
  • Highlighted the ongoing research into targeting these factors for primary prevention.

Conclusions:

  • Pediatric MS offers a unique window into early disease development and primary prevention opportunities.
  • Targeting identified early-life risk factors holds promise for reducing MS incidence.
  • Further research into perinatal and environmental determinants is crucial for effective primary MS prevention.